NANOSIGNAL NEWS - 500 Beiträge pro Seite
eröffnet am 20.04.04 18:01:05 von
neuester Beitrag 18.05.04 15:57:03 von
neuester Beitrag 18.05.04 15:57:03 von
Beiträge: 9
ID: 849.336
ID: 849.336
Aufrufe heute: 0
Gesamt: 803
Gesamt: 803
Aktive User: 0
Top-Diskussionen
| Titel | letzter Beitrag | Aufrufe |
|---|---|---|
| vor 31 Minuten | 11367 | |
| vor 32 Minuten | 6383 | |
| vor 55 Minuten | 5200 | |
| vor 1 Stunde | 4699 | |
| heute 19:18 | 3881 | |
| vor 1 Stunde | 3166 | |
| vor 1 Stunde | 2485 | |
| vor 1 Stunde | 2253 |
Meistdiskutierte Wertpapiere
| Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
|---|---|---|---|---|---|---|---|
| 1. | 2. | 18.204,00 | +0,81 | 255 | |||
| 2. | 9. | 10,580 | +9,07 | 79 | |||
| 3. | 1. | 171,43 | +1,93 | 72 | |||
| 4. | 10. | 1,2800 | +46,29 | 66 | |||
| 5. | Neu! | 86,50 | -0,23 | 36 | |||
| 6. | 16. | 6,9200 | +0,64 | 34 | |||
| 7. | Neu! | 19,234 | +11,83 | 26 | |||
| 8. | 4. | 2.325,48 | +1,03 | 23 |
Feedback
The Board of Directors of NanoSignal Corp Approve a Letter of Intent to Complete a Business Combination With a Targeted AMEX Listed Company
Tuesday April 20, 11:24 am ET
LAS VEGAS, NV--(MARKET WIRE)--Apr 20, 2004 -- NanoSignal Corp. (formerly MicroSignal Corp.) (OTC BB:NNOS.OB - News) announced today that a letter of intent has been approved by the Board of Directors to complete a business combination with a targeted American Stock Exchange (AMEX) listed company. The Board appointed Scott A. Ervin, CEO with the responsibility to successfully complete the negotiation process.
The negotiations will be geared to create a business combination whereby the AMEX listed company will offer an exchange of its shares for the shares of NNOS and several targeted roll-up companies. The business combination will be managed by an expanded Board of Directors with each roll-up entity operating on a subsidiary basis. The combined roll-up will have the assets, cash flow, market capitalization and share holder distribution base for AMEX listing. A discrete portion of existing assets and liabilities will be down-streamed in a spin-off to the existing AMEX shareholders through the issuance of preferred shares while retaining a portfolio investment in the AMEX company post roll-up.
With considerable financial negotiation success throughout his career, CEO Ervin states, "I joined NanoSignal with a mission statement to fully commercialize the company`s Slices(TM) technology serving the MRI industry. AMEX listing is merely another step in the process I started when I joined NanoSignal in February 2004. We remain committed to building shareholder value."
About NanoSignal Corp.
NanoSignal Corp. is a medical technology company introducing its patented Slices(TM) technology to the MRI industry, allowing radiologists and technologists to perform advanced imaging features beyond the capabilities of the standard MRI computer.
Information about NanoSignal Corp. is available at www.nanosignalcorp.com.
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements can be identified by the lead-in "Looking Forward." These statements are not guarantees of future performance and involve significant risks and uncertainties. Actual results may vary materially from those in the forward-looking statements as a result of the effectiveness of management`s strategies and decisions, general economic and business conditions, new or modified statutory or regulatory requirements, and changing price and market conditions. No assurance can be given that these are all the factors that could cause actual results to vary materially from the forward-looking statement.
Tuesday April 20, 11:24 am ET
LAS VEGAS, NV--(MARKET WIRE)--Apr 20, 2004 -- NanoSignal Corp. (formerly MicroSignal Corp.) (OTC BB:NNOS.OB - News) announced today that a letter of intent has been approved by the Board of Directors to complete a business combination with a targeted American Stock Exchange (AMEX) listed company. The Board appointed Scott A. Ervin, CEO with the responsibility to successfully complete the negotiation process.
The negotiations will be geared to create a business combination whereby the AMEX listed company will offer an exchange of its shares for the shares of NNOS and several targeted roll-up companies. The business combination will be managed by an expanded Board of Directors with each roll-up entity operating on a subsidiary basis. The combined roll-up will have the assets, cash flow, market capitalization and share holder distribution base for AMEX listing. A discrete portion of existing assets and liabilities will be down-streamed in a spin-off to the existing AMEX shareholders through the issuance of preferred shares while retaining a portfolio investment in the AMEX company post roll-up.
With considerable financial negotiation success throughout his career, CEO Ervin states, "I joined NanoSignal with a mission statement to fully commercialize the company`s Slices(TM) technology serving the MRI industry. AMEX listing is merely another step in the process I started when I joined NanoSignal in February 2004. We remain committed to building shareholder value."
About NanoSignal Corp.
NanoSignal Corp. is a medical technology company introducing its patented Slices(TM) technology to the MRI industry, allowing radiologists and technologists to perform advanced imaging features beyond the capabilities of the standard MRI computer.
Information about NanoSignal Corp. is available at www.nanosignalcorp.com.
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements can be identified by the lead-in "Looking Forward." These statements are not guarantees of future performance and involve significant risks and uncertainties. Actual results may vary materially from those in the forward-looking statements as a result of the effectiveness of management`s strategies and decisions, general economic and business conditions, new or modified statutory or regulatory requirements, and changing price and market conditions. No assurance can be given that these are all the factors that could cause actual results to vary materially from the forward-looking statement.
bid 0,102
ask 0,105
last 0,105
vol.4.999.978
+28%
ask 0,105
last 0,105
vol.4.999.978
+28%
Absolute Höllenfahrt.Die Amis rasten aus.
wir sehen heute noch 0,12
bid 0,107
ask 0,108
last 0,107
vol 6936943
+34%
ask 0,108
last 0,107
vol 6936943
+34%
Trading Spotlight
0,112
+40%
+40%
last 0,114
vol.26.386.308
+42,5
vol.26.386.308
+42,5
game over ! no credit,no bonus
NanoSignal Corp.`s Board of Directors Approves the Cancellation of 100 Million Shares of Common Stock
Tuesday May 18, 9:15 am ET
LAS VEGAS, NV--(MARKET WIRE)--May 18, 2004 -- NanoSignal Corp. (OTC BB:NNOSE.OB - News) is pleased to announce that the company`s Board of Directors has approved the cancellation of 100 million shares of the company`s common stock, thus reducing by one third the outstanding shares.
ADVERTISEMENT
NanoSignal`s management believes that its patent protected Slices(TM) technology can be commercialized this year and is taking all required steps, including full compliance with regulatory filing requirements to achieve that desired result for its shareholders.
CEO Scott A. Ervin stated, "Since my appointment to the office of CEO, I have been focused on the deployment and commercialization of the Slices(TM) technology. We have implemented a defined and specific plan of action to achieve this directive." Ervin continues, "I thank the Board of Directors, existing shareholders and the financial community for supporting my direction and efforts on behalf of all shareholders."
About NanoSignal Corp.
NanoSignal Corp. is a medical technology company introducing its patented Slices(TM) technology to the MRI industry, allowing radiologists and technologists to perform advanced imaging features beyond the capabilities of the standard MRI computer.
Information about NanoSignal Corp. is available at www.nanosignalcorp.com.
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements can be identified by the lead-in "Looking Forward." These statements are not guarantees of future performance and involve significant risks and uncertainties. Actual results may vary materially from those in the forward-looking statements as a result of the effectiveness of management`s strategies and decisions, general economic and business conditions, new or modified statutory or regulatory requirements, and changing price and market conditions. No assurance can be given that these are all the factors that could cause actual results to vary materially from the forward-looking statement.
Tuesday May 18, 9:15 am ET
LAS VEGAS, NV--(MARKET WIRE)--May 18, 2004 -- NanoSignal Corp. (OTC BB:NNOSE.OB - News) is pleased to announce that the company`s Board of Directors has approved the cancellation of 100 million shares of the company`s common stock, thus reducing by one third the outstanding shares.
ADVERTISEMENT
NanoSignal`s management believes that its patent protected Slices(TM) technology can be commercialized this year and is taking all required steps, including full compliance with regulatory filing requirements to achieve that desired result for its shareholders.
CEO Scott A. Ervin stated, "Since my appointment to the office of CEO, I have been focused on the deployment and commercialization of the Slices(TM) technology. We have implemented a defined and specific plan of action to achieve this directive." Ervin continues, "I thank the Board of Directors, existing shareholders and the financial community for supporting my direction and efforts on behalf of all shareholders."
About NanoSignal Corp.
NanoSignal Corp. is a medical technology company introducing its patented Slices(TM) technology to the MRI industry, allowing radiologists and technologists to perform advanced imaging features beyond the capabilities of the standard MRI computer.
Information about NanoSignal Corp. is available at www.nanosignalcorp.com.
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements can be identified by the lead-in "Looking Forward." These statements are not guarantees of future performance and involve significant risks and uncertainties. Actual results may vary materially from those in the forward-looking statements as a result of the effectiveness of management`s strategies and decisions, general economic and business conditions, new or modified statutory or regulatory requirements, and changing price and market conditions. No assurance can be given that these are all the factors that could cause actual results to vary materially from the forward-looking statement.
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 244 | ||
| 79 | ||
| 79 | ||
| 66 | ||
| 35 | ||
| 33 | ||
| 26 | ||
| 23 | ||
| 22 | ||
| 20 |
| Wertpapier | Beiträge | |
|---|---|---|
| 20 | ||
| 19 | ||
| 19 | ||
| 16 | ||
| 15 | ||
| 15 | ||
| 13 | ||
| 13 | ||
| 13 | ||
| 12 |
